We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+5.26%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$721M
AUM Growth
–
Cap. Flow
+$649M
Cap. Flow
% of AUM
89.99%
Top 10 Holdings %
Top 10 Hldgs %
24.78%
Holding
517
New
516
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$29.6M |
| 2 |
Deutsche Bank
DB
|
+$23.5M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$22.4M |
| 4 |
iShares MSCI Philippines ETF
EPHE
|
+$20.4M |
| 5 |
Home Depot
HD
|
+$13.3M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.34% |
| 2 | Healthcare | 14.73% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Financials | 9.68% |
| 5 | Industrials | 6.55% |
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Exane Derivatives, which disclosed 517 positions worth $721M. Its ten largest holdings account for 25% of the portfolio.
Its largest position is UBS Group: 1,731,016 shares worth $29.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, followed by Healthcare and Consumer Discretionary.
- Exane Derivatives's largest Q4 2014 buy was UBS Group: 1,731,016 shares worth $29.9M.
- Exane Derivatives's ten largest holdings make up 25% of its $721M portfolio in Q4 2014.
- Exane Derivatives disclosed 517 positions in Q4 2014, its first 13F filing on record.
Based on Exane Derivatives's 13F filing for Q4 2014, filed 11 Feb 2015.